Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Chronic Heart Failure

Free Subscription 22.11.2021 1 Am Heart J 7 Am J Cardiol 1 Circ Arrhythm Electrophysiol 2 Circ Cardiovasc Imaging 1 Circ Cardiovasc Qual Outcomes 12 Circ Heart Fail 3 Circulation 2 Eur Heart J 4 Eur J Heart Fail 1 Heart 4 Int J Cardiol 3 J Am Coll Cardiol 20 J Card Fail 2 J Cardiol 3 J Cardiovasc Pharmacol 2 Lancet 1 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am Heart J

1. FENDRICK AM, Djatche L, Pulungan Z, Teigland C, et al
   Out-Of-Pocket Payments for Part D Covered Medications by Medicare Fee-For-Service Beneficiaries with Heart Failure with Reduced Ejection Fraction.
   Am Heart J. 2021 Nov 10. pii: S0002-8703(21)00443.
   PubMed         Abstract available
   
   

   
   Am J Cardiol

2. LAK HM, Chawla S, Gajulapalli RD, Verma BR, et al
   Outcomes After Transfemoral Transcatheter Aortic Valve Implantation With a SAPIEN 3 Valve in Patients With Cirrhosis of the Liver (a Tertiary Care Center Experience).
   Am J Cardiol. 2021 Sep 25. pii: S0002-9149(21)00829.
   PubMed         Abstract available
   
   
3. PARIKH A, Halista M, Raymond S, Feinman J, et al
   Relation of Left Ventricular Assist Device Infections With Cardiac Transplant Outcomes.
   Am J Cardiol. 2021 Oct 3. pii: S0002-9149(21)00828.
   PubMed         Abstract available
   
   
4. ANNIE FH, Dave S, Muhammad S, Nanjundappa A, et al
   Effect of SARS-COV-2 Diagnosis on Individuals with Preexisting Chronic Heart Failure.
   Am J Cardiol. 2021 Nov 8. pii: S0002-9149(21)00993.
   PubMed        
   
   
5. MISUMI K, Matsue Y, Nogi K, Sunayama T, et al
   Usefulness of Incorporating Hypochloremia into the Get With The Guidelines-Heart Failure Risk Model in Patients With Acute Heart Failure.
   Am J Cardiol. 2021 Nov 8. pii: S0002-9149(21)00944.
   PubMed         Abstract available
   
   
6. ROBERTS WC, Khan OS
   The Syndrome of Large Healed Single Discrete Myocardial Infarct with Severe Narrowing of Only One Major Epicardial Coronary Artery and Leading to Severe Chronic Heart Failure and Orthotopic Heart Transplantation.
   Am J Cardiol. 2021;161:1-11.
   PubMed         Abstract available
   
   
7. PATOULIAS D, Papadopoulos C, Kassimis G, Boulmpou A, et al
   Updated Meta-Analysis Evaluating the Beneficial Effects of Sodium-Glucose Co-Transporter-2 Inhibitors in Patients With Heart Failure.
   Am J Cardiol. 2021;161:118-120.
   PubMed        
   
   
8. PATOULIAS D, Papadopoulos C, Toumpourleka M, Tranidou A, et al
   Meta-Analysis of Dedicated Heart Failure Trials Evaluating the Effect of Sacubitril/Valsartan on Major Cardiac Rhythm Disorders.
   Am J Cardiol. 2021;161:120-122.
   PubMed        
   
   

   
   Circ Arrhythm Electrophysiol

9. 
   Correction to: Managing Atrial Fibrillation in Patients With Heart Failure and Reduced Ejection Fraction: A Scientific Statement From the American Heart Association.
   Circ Arrhythm Electrophysiol. 2021;14:e000080.
   PubMed        
   
   

   
   Circ Cardiovasc Imaging

10. LEMOINE S, Salerno FR, Akbari A, McKelvie RS, et al
    Tissue Sodium Storage in Patients With Heart Failure: A New Therapeutic Target?
    Circ Cardiovasc Imaging. 2021;14:e012910.
    PubMed         Abstract available
    
    
11. ARAI AE, Sirajuddin A
    What Can We Learn About Heart Failure From Sodium Magnetic Resonance Imaging?
    Circ Cardiovasc Imaging. 2021;14:e013628.
    PubMed        
    
    

    
    Circ Cardiovasc Qual Outcomes

12. 
    Correction to: Improvement in Kansas City Cardiomyopathy Questionnaire Scores After a Self-Care Intervention in Patients With Acute Heart Failure Discharged From the Emergency Department.
    Circ Cardiovasc Qual Outcomes. 2021;14:e000104.
    PubMed        
    
    

    
    Circ Heart Fail

13. YUZEFPOLSKAYA M, Bohn B, Javaid A, Mondellini GM, et al
    Levels of Trimethylamine N-Oxide Remain Elevated Long Term After Left Ventricular Assist Device and Heart Transplantation and Are Independent From Measures of Inflammation and Gut Dysbiosis.
    Circ Heart Fail. 2021;14:e007909.
    PubMed         Abstract available
    
    
14. YANG JH, Choi KH, Ko YG, Ahn CM, et al
    Clinical Characteristics and Predictors of In-Hospital Mortality in Patients With Cardiogenic Shock: Results From the RESCUE Registry.
    Circ Heart Fail. 2021;14:e008141.
    PubMed         Abstract available
    
    
15. FERREIRA JP, Lamiral Z, McMurray JJV, Swedberg K, et al
    Impact of Insulin Treatment on the Effect of Eplerenone: Insights From the EMPHASIS-HF Trial.
    Circ Heart Fail. 2021;14:e008075.
    PubMed         Abstract available
    
    
16. ZHU S, Chen Z, Zhu M, Shen Y, et al
    Cardiolipin Remodeling Defects Impair Mitochondrial Architecture and Function in a Murine Model of Barth Syndrome Cardiomyopathy.
    Circ Heart Fail. 2021;14:e008289.
    PubMed         Abstract available
    
    
17. KATSURADA K, Nandi SS, Sharma NM, Patel KP, et al
    Enhanced Expression and Function of Renal SGLT2 (Sodium-Glucose Cotransporter 2) in Heart Failure: Role of Renal Nerves.
    Circ Heart Fail. 2021 Nov 18:CIRCHEARTFAILURE121008365.
    PubMed         Abstract available
    
    
18. MAHOWALD MK, Reddy YNV, Crestanello JA, Asirvatham SJ, et al
    Hemodynamic Benefits From Left Atrial Pacing to Treat Interatrial Conduction Delay Following Atrial Fibrillation Ablation.
    Circ Heart Fail. 2021 Apr 30:CIRCHEARTFAILURE120008191.
    PubMed        
    
    
19. TOPKARA VK, Clerkin KJ, Fried JA, Griffin J, et al
    Exception Status Listing in the New Adult Heart Allocation System: A New Solution to an Old Problem?
    Circ Heart Fail. 2021;14:e007916.
    PubMed         Abstract available
    
    
20. FINE NM, McMillan JM
    Prevalence and Prognostic Significance of Frailty Among Patients With Transthyretin Amyloidosis Cardiomyopathy.
    Circ Heart Fail. 2021;14:e008105.
    PubMed        
    
    
21. KHATANA SAM, Hanff TC, Nathan AS, Dayoub EJ, et al
    Association of Health Insurance Payer Type and Outcomes After Durable Left Ventricular Assist Device Implantation: An Analysis of the STS-INTERMACS Registry.
    Circ Heart Fail. 2021;14:e008277.
    PubMed         Abstract available
    
    
22. KHAN SS, Hoell C, Castillo LM, Connolly JJ, et al
    Practice Patterns After Return of Rare Variants Associated With Cardiomyopathy in the Electronic Medical Records and Genomics Network.
    Circ Heart Fail. 2021;14:e008155.
    PubMed        
    
    
23. NORDAN T, Critsinelis AC, Mahrokhian SH, Kapur NK, et al
    Bridging With Extracorporeal Membrane Oxygenation Under the New Heart Allocation System: A United Network for Organ Sharing Database Analysis.
    Circ Heart Fail. 2021;14:e007966.
    PubMed         Abstract available
    
    
24. SHAH P, Psotka M, Taleb I, Alharethi R, et al
    Framework to Classify Reverse Cardiac Remodeling With Mechanical Circulatory Support: The Utah-Inova Stages.
    Circ Heart Fail. 2021;14:e007991.
    PubMed         Abstract available
    
    

    
    Circulation

25. PFEFFER MA, Claggett B, Lewis EF, Granger CB, et al
    Impact of Sacubitril/Valsartan Versus Ramipril on Total Heart Failure Events in the PARADISE-MI Trial.
    Circulation. 2021 Nov 19. doi: 10.1161/CIRCULATIONAHA.121.057429.
    PubMed        
    
    
26. BUTLER J, Filippatos G, Siddiqi TJ, Brueckmann M, et al
    Empagliflozin, Health Status, and Quality of Life in Patients with Heart Failure and Preserved Ejection Fraction: The EMPEROR-Preserved Trial.
    Circulation. 2021 Nov 15. doi: 10.1161/CIRCULATIONAHA.121.057812.
    PubMed         Abstract available
    
    
27. FILIPPATOS G, Anker SD, Agarwal R, Ruilope LM, et al
    Finerenone Reduces Risk of Incident Heart Failure in Patients With Chronic Kidney Disease and Type 2 Diabetes: Analyses from the FIGARO-DKD Trial.
    Circulation. 2021 Nov 13. doi: 10.1161/CIRCULATIONAHA.121.057983.
    PubMed         Abstract available
    
    

    
    Eur Heart J

28. PITT B, Ferreira JP, Zannad F
    Why are mineralocorticoid receptor antagonists the Cinderella in evidence-based treatment of myocardial infarction complicated with heart failure? Lessons from PARADISE-MI.
    Eur Heart J. 2021 Nov 12. pii: 6425576. doi: 10.1093.
    PubMed        
    
    
29. CREA F
    Mechanisms of heart failure with preserved ejection fraction, risk stratification of heart failure with reduced ejection fraction, and new light on resistance to diuretics in acute decompensated heart failure.
    Eur Heart J. 2021;42:4405-4409.
    PubMed        
    
    

    
    Eur J Heart Fail

30. EMMENS JE, Ter Maaten JM, Matsue Y, Figarska SM, et al
    Worsening renal function in acute heart failure in the context of diuretic response.
    Eur J Heart Fail. 2021 Nov 17. doi: 10.1002/ejhf.2384.
    PubMed         Abstract available
    
    
31. GREENE SJ, Butler J, Fonarow GC
    In-hospital Initiation of Quadruple Medical Therapy for Heart Failure: Making the Post-Discharge Vulnerable Phase Far Less Vulnerable.
    Eur J Heart Fail. 2021 Nov 14. doi: 10.1002/ejhf.2382.
    PubMed        
    
    
32. BUTT JH, Docherty KF, Jhund PS, De Boer RA, et al
    Dapagliflozin and atrial fibrillation in heart failure with reduced ejection fraction: Insights from DAPA-HF.
    Eur J Heart Fail. 2021 Nov 11. doi: 10.1002/ejhf.2381.
    PubMed         Abstract available
    
    
33. TER MAATEN JM, Beldhuis IE, van der Meer P, Krikken JA, et al
    Natriuresis guided therapy in acute heart failure: rationale and design of the Pragmatic Urinary Sodium-based Treatment algoritHm in Acute Heart Failure (PUSH-AHF) trial.
    Eur J Heart Fail. 2021 Nov 17. doi: 10.1002/ejhf.2385.
    PubMed         Abstract available
    
    

    
    Heart

34. GUO X, Song R, Chen Y
    Severe aortic regurgitation and heart failure.
    Heart. 2021;107:1874-1924.
    PubMed        
    
    

    
    Int J Cardiol

35. TEMPORELLI PL, Arbelo E, Laroche C, Blomstrom-Lundqvist C, et al
    Atrial fibrillation ablation in heart failure: Findings from the ESC-EHRA EORP Atrial Fibrillation Ablation long-term (AFA LT) registry.
    Int J Cardiol. 2021 Nov 11. pii: S0167-5273(21)01779.
    PubMed         Abstract available
    
    
36. MO M, Xia N, Liao Y
    Letter on "Effects of SGLT2 inhibitors on cardiovascular, renal, and major safety outcomes in heart failure: A meta-analysis of randomized controlled trials".
    Int J Cardiol. 2021 Nov 13. pii: S0167-5273(21)01839.
    PubMed        
    
    
37. GORI M, Marini M, De Maria R, Gonzini L, et al
    Age-related changes in clinical characteristics and outcomes of chronic heart failure outpatients in a cardiology setting. A report from the Italian Network on Heart Failure.
    Int J Cardiol. 2021 Nov 15. pii: S0167-5273(21)01783.
    PubMed         Abstract available
    
    
38. PFEIFER P, Zietzer A, Holscher M, Jehle J, et al
    Transverse aortic constriction-induced heart failure leads to increased levels of circulating microparticles.
    Int J Cardiol. 2021 Nov 10. pii: S0167-5273(21)01772.
    PubMed         Abstract available
    
    

    
    J Am Coll Cardiol

39. PALAU P, Seller J, Dominguez E, Sastre C, et al
    Effect of beta-Blocker Withdrawal on Functional Capacity in Heart Failure and Preserved Ejection Fraction.
    J Am Coll Cardiol. 2021;78:2042-2056.
    PubMed         Abstract available
    
    
40. GOTTLIEB SH
    Heart Failure With Reduced Ejection Fraction: "Guideline-Directed Medical Therapy (GDMT)" Versus "The Art of Medicine".
    J Am Coll Cardiol. 2021;78:2013-2016.
    PubMed        
    
    
41. RAO VN, Murray E, Butler J, Cooper LB, et al
    In-Hospital Initiation of Sodium-Glucose Cotransporter-2 Inhibitors for Heart Failure With Reduced Ejection Fraction.
    J Am Coll Cardiol. 2021;78:2004-2012.
    PubMed         Abstract available
    
    

    
    J Card Fail

42. GABISONIA K, Burjanadze G, Woitek F, Keles A, et al
    Proteome dynasmics and bioinformatics reveal major alterations in the turnover rate of functionally related cardiac and plasma proteins in a dog model of congestive heart failure.
    J Card Fail. 2021 Nov 13. pii: S1071-9164(21)00471.
    PubMed         Abstract available
    
    
43. MORRIS KL, Sheikh F, Ravichandran A
    Implementing a PARADIGM Shift.
    J Card Fail. 2021;27:837-838.
    PubMed        
    
    
44. AMDANI S, Bhimani SA, Boyle G, Liu W, et al
    Racial and Ethnic Disparities Persist in the Current Era of Pediatric Heart Transplantation.
    J Card Fail. 2021;27:957-964.
    PubMed         Abstract available
    
    
45. BHATT AS, Claggett BL, Packer M, Lefkowitz MP, et al
    Treatment Effects of Sacubitril/Valsartan Compared With Valsartan by Ejection Fraction in Patients With Recent Hospitalization.
    J Card Fail. 2021;27:1027-1030.
    PubMed        
    
    
46. KONTOROVICH AR, Abul-Husn NS
    Retinol Binding Protein 4 as a Screening Biomarker for Hereditary TTR Amyloidosis in African American Adults With TTR V142I.
    J Card Fail. 2021;27:1020-1022.
    PubMed        
    
    
47. DUGAN E, Ferraro R, Hamo C, Ambinder D, et al
    The CardioNerds #CardsJC: How Twitter Journal Clubs Elevate the Scientific Discourse.
    J Card Fail. 2021;27:1034-1036.
    PubMed        
    
    
48. BRENER MI, Hamid NB, Fried JA, Masoumi A, et al
    Right Ventricular Pressure-Volume Analysis During Left Ventricular Assist Device Speed Optimization Studies: Insights Into Interventricular Interactions and Right Ventricular Failure.
    J Card Fail. 2021;27:991-1001.
    PubMed         Abstract available
    
    
49. GREENE SJ, Butler J, Hellkamp AS, Spertus JA, et al
    Comparative Effectiveness of Dosing of Medical Therapy for Heart Failure: From the CHAMP-HF Registry.
    J Card Fail. 2021 Oct 8. pii: S1071-9164(21)00393.
    PubMed         Abstract available
    
    
50. OZAKI AF, Krumholz HM, Mody FV, Jackevicius CA, et al
    National Trends in the Use of Sacubitril/Valsartan.
    J Card Fail. 2021;27:839-847.
    PubMed         Abstract available
    
    
51. KELLEY G
    You Are Here For a Reason.
    J Card Fail. 2021;27:1037-1038.
    PubMed        
    
    
52. JUGGAN S, Ponnamreddy PK, JrRiley C, Dodge SE, et al
    Comparative effectiveness of CRT in older patients with heart failure: Systematic review and meta-analysis.
    J Card Fail. 2021 Nov 10. pii: S1071-9164(21)00439.
    PubMed         Abstract available
    
    
53. WARIAR R, Wen G, Jacobsen C, Ruble S, et al
    Evaluation of Medicare Claims for Heart Failure Diagnostic Development.
    J Card Fail. 2021 Nov 11. pii: S1071-9164(21)00467.
    PubMed         Abstract available
    
    
54. VADUGANATHAN M, Greene SJ, Zhang S, Solomon N, et al
    Projected Clinical Benefits of Implementation of SGLT-2 Inhibitors among Medicare Beneficiaries Hospitalized for Heart Failure.
    J Card Fail. 2021 Nov 13. pii: S1071-9164(21)00470.
    PubMed         Abstract available
    
    
55. MASTORIS I, Van Spall HGC, Sheldon SH, Pimentel RC, et al
    Emerging Implantable Device Technology for Patients at the Intersection of Electrophysiology and Heart Failure Interdisciplinary Care.
    J Card Fail. 2021 Nov 10. pii: S1071-9164(21)00465.
    PubMed         Abstract available
    
    
56. MORICI N, Marini C, Sacco A, Tavazzi G, et al
    Intra-aortic balloon pump for acute-on-chronic heart failure complicated by cardiogenic shock.
    J Card Fail. 2021 Nov 10. pii: S1071-9164(21)00468.
    PubMed         Abstract available
    
    
57. PRESSLER SJ, Jung M, Gradus-Pizlo I, Titler M, et al
    Randomized Controlled Trial of a Cognitive Intervention to Improve Memory in Heart Failure.
    J Card Fail. 2021 Nov 8. pii: S1071-9164(21)00434.
    PubMed         Abstract available
    
    
58. APOSTOLO A, Vignati C, Della Rocca M, de Martino F, et al
    Why Levosimendan improves the clinical condition of patients with advanced heart failure: a holistic approach.
    J Card Fail. 2021 Nov 8. pii: S1071-9164(21)00435.
    PubMed         Abstract available
    
    
59. MEHTA R, Ning H, Bansal N, Cohen J, et al
    10-Year Risk Prediction Equations for Incident Heart Failure Hospitalizations in Chronic Kidney Disease: Findings from the Chronic Renal Insufficiency Cohort Study and the Multi-Ethnic Study of Atherosclerosis.
    J Card Fail. 2021 Nov 8. pii: S1071-9164(21)00433.
    PubMed         Abstract available
    
    
60. HEIDENREICH P, Jasak B
    Medicare in the Age of COVID: A Case Study in HFSA Advocacy.
    J Card Fail. 2021;27:1039-1040.
    PubMed        
    
    
61. LALA A, Tayal U, Hamo CE, Youmans Q, et al
    Sex Differences in Heart Failure.
    J Card Fail. 2021 Nov 6. pii: S1071-9164(21)00432.
    PubMed         Abstract available
    
    

    
    J Cardiol

62. TSAI YL, Chou RH, Lu YW, Chang CC, et al
    Associations between galectin-1, left ventricular diastolic dysfunction, and heart failure with preserved ejection fraction.
    J Cardiol. 2021 Nov 10. pii: S0914-5087(21)00258.
    PubMed         Abstract available
    
    
63. OKADA M, Inoue K
    Catheter ablation of atrial fibrillation with left ventricular systolic dysfunction: Potential approach to the cause of heart failure-authors' reply.
    J Cardiol. 2021;78:347-348.
    PubMed        
    
    

    
    J Cardiovasc Pharmacol

64. AMRITPHALE A
    Right Heart Failure Management: the Achilles heel.
    J Cardiovasc Pharmacol. 2021 Nov 3. pii: 00005344-900000000-98115.
    PubMed        
    
    
65. FERNANDES C, Antonio N, Marinho V, Milner J, et al
    Digoxin in patients with advanced heart failure and sinus rhythm submitted to cardiac resynchronization therapy- is there any benefit?
    J Cardiovasc Pharmacol. 2021 Nov 3. pii: 00005344-900000000-98116.
    PubMed         Abstract available
    
    
66. VIDER E, Sapir R, Mosseri E, Gavioli E, et al
    Current perspectives of the use of Sodium Glucose Transport-2 Inhibitors for patients with heart failure and chronic kidney disease.
    J Cardiovasc Pharmacol. 2021 Nov 3. pii: 00005344-900000000-98119.
    PubMed         Abstract available
    
    

    
    Lancet

67. FIGTREE GA, Vernon ST, Hadziosmanovic N, Sundstrom J, et al
    Mortality in STEMI patients without standard modifiable risk factors: a sex-disaggregated analysis of SWEDEHEART registry data.
    Lancet. 2021;397:1085-1094.
    PubMed         Abstract available
    
    
68. 
    Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-level data meta-analysis.
    Lancet. 2021 Aug 26. pii: S0140-6736(21)01921.
    PubMed         Abstract available
    
    

    
    PLoS One

69. GALLARD A, Galli E, Hubert A, Bidaut A, et al
    Echocardiographic view and feature selection for the estimation of the response to CRT.
    PLoS One. 2021;16:e0252857.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Chronic Heart Failure is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: